Compare Monolithic Power Systems Inc (MPWR) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monolithic Power Systems Inc vs TG Therapeutics Inc — how do they compare? Monolithic Power Systems Inc trades at $1,383 (market cap $65.28B), while TG Therapeutics Inc trades at $54 (market cap $8.26B). The key difference: Monolithic Power Systems Inc is far larger — about 7.9× TG Therapeutics Inc's market cap, and Monolithic Power Systems Inc pays a 0.6% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MPWR | TGTX | |
|---|---|---|
Market Cap | $65.28B | $8.26B |
Sector | Utilities | Health |
52-Week High | $1.69K | $59.06 |
52-Week Low | $711.24 | $26.39 |
Enterprise Value | $63.94B | $8.50B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
